Benjamin Bulkley Net Worth

The estimated Net Worth of Benjamin Bulkley is at least $113 Thousand dollars as of 19 September 2008. Benjamin Bulkley owns over 8,253 units of Rite Aid stock worth over $5,574 and over the last 17 years Benjamin sold RAD stock worth over $107,289.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Benjamin Bulkley RAD stock SEC Form 4 insiders trading

Benjamin has made over 1 trades of the Rite Aid stock since 2008, according to the Form 4 filled with the SEC. Most recently Benjamin sold 8,253 units of RAD stock worth $107,289 on 19 September 2008.

The largest trade Benjamin's ever made was selling 8,253 units of Rite Aid stock on 19 September 2008 worth over $107,289. On average, Benjamin trades about 1,179 units every 0 days since 2007. As of 19 September 2008 Benjamin still owns at least 8,575 units of Rite Aid stock.

You can see the complete history of Benjamin Bulkley stock trades at the bottom of the page.

What's Benjamin Bulkley's mailing address?

Benjamin's mailing address filed with the SEC is 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO, IL, 60654.

Insiders trading at Rite Aid

Over the last 45 years, insiders at Rite Aid have traded over $704,219,544 worth of Rite Aid stock and bought 1,989,612 units worth $9,286,101 . The most active insiders traders include Coutu Group (Pjc) Inc. Jean, John M Baumer, and Equity Investors Iii Lpgei .... On average, Rite Aid executives and independent directors trade stock every 238 days with the average trade being worth of $2,811,488. The most recent stock trade was executed by Heyward R Donigan on 22 December 2021, trading 14,350 units of RAD stock currently worth $199,896.

What does Rite Aid do?

riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.

Complete history of Benjamin Bulkley stock trades at Veradigm Inc and Rite Aid

Rite Aid executives and stock owners

Rite Aid executives and other stock owners filed with the SEC include:

• Heyward Donigan,
  President, Chief Executive Officer, Director
• Heyward Rutledge Donigan B.A.,
  Pres CEO & Director
• Jocelyn Konrad,
  Executive Vice President - Pharmacy and Retail Operations
• Matthew Schroeder,
  Chief Financial Officer, Senior Vice President
• James Peters,
  Chief Operating Officer
• Jocelyn Zazyczny Konrad,
  Exec. VP & Chief Pharmacy Officer
• James Joseph Peters Jr.,
  Chief Operating Officer
• Matthew C. Schroeder,
  CFO & Exec. VP
• Justin L. Mennen,
  Exec. VP & Chief Information Officer
• Bruce Bodaken,
  Independent Chairman of the Board
• Louis Miramontes,
  Independent Director
• Arun Nayar,
  Independent Director
• Kevin Lofton,
  Independent Director
• Robert Knowling,
  Independent Director
• Marcy Syms,
  Independent Director
• Elizabeth Burr,
  Independent Director
• Katherine Quinn,
  Independent Director
• Bari Harlam,
  Independent Director
• Paul Gilbert,
  General Counsel, Company Secretary
• Brian Hoover,
  Chief Accounting Officer
• Roxanne Schwans,
  Senior Vice President - Market Access and Pharmacy Purchasing
• Angele Robinson-Gaylord,
  Senior Vice President - Store Development
• Chris Bohrer,
  Senior Vice President - Payor and Strategic Initiatives
• Trent Kruse,
  Senior Vice President of Investor Relations, Treasury
• Erik Keptner,
  Senior Vice President, Chief Marketing Officer
• Justin Mennen,
  Senior Vice President, Chief Information Officer
• Andre Persaud,
  Executive Vice President - Retail
• Susan K. Henderson,
  Chief Communications Officer & Sr. VP
• Paul D. Gilbert,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Byron Purcell,
  Sr. Director of Treasury Services & Investor Relations
• Brian T. Hoover,
  Chief Accounting Officer & Sr. VP
• Michel Coutu,
  Director
• James Donald,
  Director
• Steven Bixler,
  Chief Accounting Officer
• Bryan B Everett,
  CHIEF OPERATING OFFICER
• Frank A Savage,
  Director
• Michael N Regan,
  Director
• Myrtle S Potter,
  Director
• Joseph B Jr Anderson,
  Director
• Castle Dedra Newman,
  EVP
• David Jessick,
  Director
• John T Standley,
  Senior EVP & CAO
• David Abelman,
  EVP
• Tony Montini,
  EVP
• Darren W Karst,
  EVP & CFO
• Kermit R Crawford,
  President and COO
• Jessica Kazmaier,
  EVP, Chief HR Officer
• James J Comitale,
  EVP, General Counsel, Secy.
• Matt Schroeder,
  EVP, Chief Financial Officer
• Derek S. Griffith,
  Field EVP, Store Operations
• Benjamin Bulkley,
  CEO EnvisionRXOptions
• Kenneth Martindale,
  Senior Executive VP
• Andre Belzile,
  Director
• Dennis Wood,
  Director
• Philip G Satre,
  Director
• Robert Gerald Miller,
  Director
• Pierre Legault,
  Senior EVP - CAO
• Equity Investors Iii Lpgree...,
  
• Stuart M Sloan,
  Director
• Douglas E Donley,
  Senior VP and CAO
• Colin V Reed,
  Director
• Robert Sari,
  SVP AND GENERAL COUNSEL and
• Michael A Friedman,
  Director
• Jonathan Ddanhakl John G So...,
  
• George Golleher,
  Director
• Robert J Easley,
  Chief Operating Officer
• Mary F Sammons,
  PRESIDENT & CEO
• Bruin Jerry Mark De,
  EVP, Pharmacy
• Mark C Panzer,
  SR. EVP - Store Operations
• Alfred Gleason,
  Director
• Equity Investors Iii Lpgree...,
  
• Kevin Twomey,
  SVP & CHIEF ACCOUNTING OFFICER
• Robert A Mariano,
  Director
• James P Mastrian,
  SR.EVP.- Category Management
• Christopher Hall,
  EVP and CFO
• Robert K Thompson,
  EVP
• Robert Ivan Thompson,
  EVP - Pharmacy
• Frank Vitrano,
  Chief Admin. Officer & CFO
• Marc A Strassler,
  EVP,General Counsel
• Coutu Group (Pjc) Inc. Jean,
  10% owner
• Brian Fiala,
  Executive VP, Operations
• Equity Investors Iii Lpgei ...,
  
• John M Baumer,
  Director
• Francois J Coutu,
  Director
• Dan Robson,
  President, EnvisionRXOptions
• Ray Smithberger,
  SVP, Operations